Researchers at the University of Ottawa have mapped out a dual-action therapeutic strategy to cross the blood-brain barrier and eliminate pathological proteins linked to Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), and dementia Published... [2110 chars]